NCT01579786

Brief Summary

The aim of the study was to evaluate if acupuncture may reduce intraoperative ULTIVA (remifentanil) consumption and post operative pain measured with VAS, italian version Mc Gill Questionnaire Pain and drug consumption (acetaminophen daily consumption).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
121

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

February 20, 2014

Status Verified

February 1, 2014

Enrollment Period

1.6 years

First QC Date

April 3, 2012

Last Update Submit

February 19, 2014

Conditions

Keywords

post operative painacupuncture

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    Change in intensity of pain from first day after operation and during the seven days after performing surgery

    within the 3rd postoperative day

Secondary Outcomes (1)

  • Mc Gill Questionnaire pain

    within the 3rd postoperative day

Other Outcomes (2)

  • Remifentanil consumption

    Intraoperative

  • Acetaminophen

    within 7 days after surgery

Study Arms (2)

Acetaminophen

NO INTERVENTION

A group All patients will be treated only with drugs used for this type during the operation and post operative pain controlled with usual acetaminophen drug administration (maximum 3 g/day)

Acetaminophen and acupuncture

EXPERIMENTAL

B group patients. All patients will receive the standard pharmacological treatment for the operation. Acetaminophen (maximum 3g/day) during all seven days after surgery and patients will be treated with acupuncture the first day after surgery and thirty minutes before the surgical procedure

Procedure: Acetaminophen and acupuncture

Interventions

All patients will receive acetaminophen (maximum 3g/day) for all seven days after surgery and will receive acupuncture treatment at first day after performing surgery and thirty minutes before operation

Also known as: Acupuncture
Acetaminophen and acupuncture

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • thyroid surgery patients

You may not qualify if:

  • back severe arthritis
  • osteoporosis
  • myofascial pain
  • rheumatic disease
  • fibromyalgia
  • systemic cardiovascular and respiratory disease
  • hypertension
  • drug or alcohol consumption
  • mental disease
  • cervical trauma
  • chronic use of antidepressant
  • hypnotic and antihypertensive drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endocrine Unit, Padova Universitary Hospital

Padua, Padova, 35128, Italy

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

AcetaminophenAcupuncture Therapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesComplementary TherapiesTherapeutics

Study Officials

  • Professor Nitti, Donato

    University of Pdova

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ordinary Professor of Surgery

Study Record Dates

First Submitted

April 3, 2012

First Posted

April 18, 2012

Study Start

May 1, 2011

Primary Completion

December 1, 2012

Study Completion

February 1, 2014

Last Updated

February 20, 2014

Record last verified: 2014-02

Locations